|
ISSUE 9, FEB 1997CONTENT: · PHARMACEUTICAL MARKET A Continuation of Slack in Trade Fair of Finished Pharmaceuticals Bulk Drugs Trade Fair Ends the Bleak 1996 · FINE CHEMICALS Bright Prospects for Sino-Foreign Cooperation in the Field of Fine Chemicals · FEATURE ARTICLE New Guidelines for Foreign Investment in Medical Industry · I&E STATISTICS Medicines Import & Export Data from China Customs · ADMINISTRATIVE PROTECTION Approval Announcements Granting Administrative Protection Recent Applications for Administrative Protection Announcement Terminating Administrative Protection for Lastet · MARKET QUOTATION Recent Market Quotations of Commonly-used Drugs in Five Regions · COMPANY PROFILE Novo Nordisk Produces Insulin in Tianjin; "Reform Monthly" Acquired Zhenan Pharm.; Roche Sets up Another JV; Guangzhou Pharm. Group Formed; Oz Productions Acquires Dalian Pegasus; Top 10 Pharm. Majors in Shanghai; American Autodata Sets up Ophthalmologic Center in China; 1996 - A Harvest Year for North China Pharm.; Chengdu Pharm. Established; Jiangsu Yangtze Pharm. Bid US$8M for CCTV Prime-time Ad.; GMP Solid Preparation Plant into Production; Xian-Janssen Benefits from the Bank Support; Shandong Lukang Issues A-share; Four Chinese Drugmakers will be Listed Overseas; Large-Volume Parenteral Line into Production; Guangdong Weida Acquires Nanjing Tianyu; Yunnan Baiyao Group Established; Hebei Baoyuan into Production; Xinhua Gains Success on Hong Kong Stock Market; · PRODUCT NEWS Satylin Approved for Trial Production; IFN-2b into Scale Production; Alfa-Calciferol Obtained NDC; Joint Production of New Hepatitis B Vaccine; Anti-Hepatitis B Transfer Factor Marketed; Natural -Carotene Evaluated; Anti-Bone Tumor Drug Marketed; Cyclosporin A Soft Capsule Produced; Test Kit for Early Liver Fibrillation Developed; Piroxicam Marketed; Cordyceps Capsule Approved by FDA; P-Hydroxyphenylglycine Produced at Haimen Pharm.; Counterfeit Cephradine Found; Colorado Glaucoma Therapeutic Equipment to Enter China; · NEWS IN BRIEF Tong Ren Tang Identified as the Well-known Trademark; Supervision on Medical Equipment Standardized; MPH Reports 83% of Drugs Qualified; Hunan Pharm. will be Listed; R&D Center of Herbal Medicines to be Built up; China Lays out a 15-year Target for Medical Technologies; The Ten Most Important Med-tech News of 1996 Released; Morbidity of Cancers Changes Markedly in Shanghai; Morbidity and Mortality of Cancer Significantly Increase; 1/3 Packaging Materials for Medicines Substandard; Shanghai Sets Goals for Development of Medicines by 2000; Electrocardiogram Telephone Center Commences Operation; Tianjin SK&F Sets Scholarship; GCP Seminar; International Symposium on Proton Therapy; Results of Quality Inspection on Medical Devices Released; Anhui Province Orientates to Biopharmaceuticals; Nanjing Forms Hospital Group; Share-holding Hospital Opened; Zhejiang Sets up Diabetes Center; Wanjie Hospital Imports the First Photon Knife; Seminar on Intervention Medicine; Symposium on Antiepileptics Drug; 118 Generic Drugs Available in Shanghai Supermarket; ADR Supervision Center Established in Tianjin; Hangzhou Reforms Fee System; Beijing Emphases R&D of Bioengineering and New Drugs; Tongji-IAB Center for Drug Research Established; Egypt Will Export US$40 Million Drugs to China; |
|